Safety Study of Tritanrix-HepB/Hib-MenAC, Tritanrix-HepB/Hiberix, and Mencevax ACWY Vaccines in Children

Clinical trial NCT00228917 · COMPLETED

Trial details

NCT number: NCT00228917
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Whole Cell Pertussis Tetanus Hepatitis B Diphtheria Haemophilus Influenzae Type b Diphtheria-Tetanus-Pertussis-Hepatitis B-Haemophilus Influenzae Type b-Neisseria Meningitidis Vaccin

Start date: 2005-06-16
Primary completion: 2006-01-20
Enrollment: 798

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.